Amyotrophic Lateral Sclerosis

Author: Rosalyn Carson-DeWitt, MD

Definition

Amyotrophic lateral sclerosis (ALS) is a progressive nervous system disorder. It gradually destroys the nerves responsible for muscle movement. Over time, ALS leads to almost total paralysis of muscle movement, including respiration.

Prognosis is poor in most cases because of the progressive nature of the condition and the eventual respiratory failure. After diagnosis is made, life span ranges from 2-5 years. The five-year survival rate ranges from 14%-25%, and up to 10% of patients will survive more than 10 years. In general, the younger the age of onset, the slower the disease progresses.

The Nervous System

Nucleus factsheet image
© 2011 Nucleus Medical Media, Inc.

Causes

The cause of ALS is not known, but in a small number of cases, it appears that genes may have played a role. Also, research has shown that there may be a reduced response to cell stress, as well as cell toxicity, related to certain protein build-up in the brain.

Risk Factors

A risk factor is something that increases your chance of getting a disease or condition. Risk factors include:

  • Having a family member with ALS
  • Being in the military or having other occupations
  • Having certain genetic mutations

Symptoms

Symptoms include:

  • Progressive weakness in arms and legs (at first often on only one side) over weeks to months without changes in sensory abilities.
  • Initial presentation may be a wrist or foot drop
  • Trouble holding things without dropping them
  • Frequent tripping while walking
  • Shrunken muscles
  • Twitchy muscles
  • Unpredictable changing emotions
  • Clumsiness
  • Overactive reflexes
  • Slurred speech
  • Hoarseness
  • Trouble chewing and swallowing, resulting in frequent choking and gagging
  • Weight loss due to trouble eating
  • Trouble breathing
  • Excess salivation, drooling
  • Cognition is intact
  • Sensation is intact
  • Trouble coughing, resulting in development of pneumonia

Diagnosis

The doctor will ask about your symptoms and medical history, and do a physical exam. There are no tests that definitively diagnose ALS, but tests may be used to rule out other medical conditions.

Tests may include:

  • Electromyogram (EMG) —to look for progressive muscle weakness and twitching
  • CT Scan —a type of x-ray that uses a computer to make pictures of the structures inside the head and spine
  • MRI Scan —a test that uses magnetic waves to make pictures of the structures inside the head and spine
  • Blood tests—to rule out metabolic, heavy metal exposure, or rarely infections (eg, Lyme disease, HIV, human T-lymphotropic virus)
  • Lumbar puncture —a procedure to collect cerebrospinal fluid (CSF)
  • Urine tests

Treatment

There is currently no cure for ALS.

For you and your family, a multidisciplinary approach may work best. This approach may include:

  • Taking medicines
  • Working with therapists and joining a support group
  • Participating in religious and social activities

Treatments options include:

Medications

The drug riluzole has been approved for ALS with a clinical trial revealing a modest lengthening of survival. The drug may slightly improve functioning, but it does not stop the disease from progressing. Other drugs are also being studied.

Your doctor may prescribe these medicines for symptoms

Other Types of Treatments

  • Physical therapy—This is used to reduce pain associated with muscle cramping and spasticity.
  • Respiratory care—In some cases, you may need to receive a mixture of air and oxygen from a machine. If you cannot move enough air in and out of your lungs, you may need surgery to have a tube inserted into your airway.
  • Nutritional care—Your doctor may make changes to your diet. In some cases, getting nutrition through tube feeding is needed.
  • Speech therapy—Speech therapy may be used to optimize communication. Therapy can include exploring alternative methods of communication.

Prevention

There are no guidelines for preventing ALS because the cause is unknown.

Resources:

ALS Association

http://www.alsa.org/

National Institute of Neurological Disorders and Stroke

http://www.ninds.nih.gov/

Canadian Resources:

ALS Society of BC

http://www.alsbc.ca/

ALS Society of Canada

http://www.als.ca/

References:

Aggarwal, SP, Zinman L, Simpson E, et al. Clinical trial testing lithium in ALS terminates early for futility. Lancet Neurol. 2010; 9(5): 481-488.

Amyotrophic lateral sclerosis. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated July 2011. Accessed August 6, 2011.

Amyotrophic lateral sclerosis fact sheet. National Institute of Neurological Disorders and Stroke website. Available at: http://www.ninds.nih.gov/disorders/amyotrophiclateralsclerosis/detail_amyotrophicl...ralsclerosis.htm. Published April 2003. Accessed July 8, 2009.

Bradley WG, Daroff RB. Neurology In Clinical Practice. Philadelphia, PA: Butterworth Heinemann Publishing; 2004.

Goetz CG. Textbook of Clinical Neurology. Philadelphia, PA: WB Saunders Company; 1999.

Kasper DL, Braunwald E, Fauci AS, et al. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: The McGraw-Hill Companies; 2005.

Lou JS. Amyotrophic lateral sclerosis. In: Gilman S, ed. MedLink Neurology. San Diego, CA: MedLink Corporation. Available at: http://www.medlink.com. Accessed February 4, 2009.

Miller RG, Mitchell JD, Lyon M, et al. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). The Cochrane Library. Chichester, England: John Wiley & Sons, Ltd; 2005.

Samuels MA, Feske SK. Office Practice of Neurology. Philadelphia, PA: Churchill Livingstone; 2003.

Sathasivam S. Managing patients with amyotrophic lateral sclerosis. Eur J Intern Med. 2009;24:355-358.

Walling AD. Amyotrophic lateral sclerosis: Lou Gehrig's disease. Am Fam Physician. 1999;59:1489-1496.

4/17/2008 DynaMed Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance: Fornai F, Longone P, Cafaro L, et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2008;105:2052-2057.

1/14/2011 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance: Mateen FJ, Carone M, Sorenson EJ. Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004. J Neurol Neurosurg Psychiatry. 2010;81(10):1144-1146.

Last reviewed August 2011 by Marjorie Bunch, MD

Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.

Back